Login / Signup

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer's disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial.

Yun Jeong HongHyun Jeong HanYoung Chul YounKyung Won ParkDong Won YangSangYun KimHwa Jung KimJi Eun KimJae-Hong Leenull null
Published in: Alzheimer's research & therapy (2019)
Clinicaltrials.gov , NCT02550665. Retrospectively registered on 15 Sep 2015.
Keyphrases
  • open label
  • phase iii
  • phase ii
  • double blind
  • clinical trial
  • study protocol
  • placebo controlled
  • phase ii study
  • cognitive decline
  • randomized controlled trial
  • cross sectional
  • squamous cell carcinoma
  • radiation therapy